Paul J. Sekhri, President, CEO and Executive Chairperson at vTv Therapeutics Inc. (VTVT), bought 5,000 shares at $16.88 ($84K) on 2024-11-15, disclosed to the SEC on 2024-11-19.
Scheduled purchase ($84k) by President, CEO and Executive Chairperson under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.35 | 1,378 | $23K | 26.9% |
| 2 | $16.88 | 1,778 | $30K | 35.8% |
| 3 | $16.96 | 1,844 | $31K | 37.3% |
| Total | $16.76 avg | 5,000 | $84K | 100% |
| Filing → |
| VEEV | SELL | 2023-03-06 | $484K | — | Filing → |
| VEEV | SELL | 2022-04-01 | $2.4M | — | Filing → |
| PHGE | BUY | 2021-07-30 | $50K | — | Filing → |